Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Netanya S Utay

Showing results (1-10 of 51) with videos related to

Pageof 6
Sort By:
Current Opinion in HIV and AIDS|June 14, 2024
Therapeutic microbiome modulation: new frontiers in HIV treatmentRene Bulnes, Netanya S Utay
Current Opinion in Infectious Diseases|July 24, 2015
A new era of therapy for hepatitis C virus infectionHarita Nyalakonda, Netanya S Utay
Current Opinion in HIV and AIDS|January 6, 2016
Role of immune activation in progression to AIDSNetanya S Utay, Peter W Hunt
Current HIV/AIDS Reports|February 10, 2015
Type I interferon: understanding its role in HIV pathogenesis and therapySteven E Bosinger, Netanya S Utay
Tropical Diseases, Travel Medicine and Vaccines|September 9, 2017
Hepatic steatosis in HCV-infected persons in the direct-acting antiviral eraHeather L Stevenson, Netanya S Utay
Pathogens & Immunity|August 9, 2016
Interferons and HIV Infection: The Good, the Bad, and the UglyNetanya S Utay, Daniel C Douek
Expert Opinion on Investigational Drugs|December 16, 2015
Peginterferon α-2a for the treatment of HIV infectionDavid M Asmuth, Netanya S Utay, Richard B Pollard
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|May 28, 2025
Low Rate of Documented Measles Immunity in a Large Urban HIV ClinicHayden S Andrews, Hannah L Blanchard, Shining Yang, et al.
Transactions of the American Clinical and Climatological Association|July 18, 2020
THE INTESTINAL MICROBIOME IN HUMAN HEALTH AND DISEASEHerbert L Dupont, Zhi-Dong Jiang, Andrew W Dupont, et al.
Digestive Diseases and Sciences|February 3, 2020
Abnormal Intestinal Microbiome in Medical Disorders and Potential Reversibility by Fecal Microbiota TransplantationHerbert L DuPont, Zhi-Dong Jiang, Andrew W DuPont, et al.
Pageof 6

Showing results (1-10 of 51) with videos related to

Sort By:
Pageof 6
Current Opinion in HIV and AIDS|June 14, 2024
Therapeutic microbiome modulation: new frontiers in HIV treatmentRene Bulnes, Netanya S Utay
Current Opinion in Infectious Diseases|July 24, 2015
A new era of therapy for hepatitis C virus infectionHarita Nyalakonda, Netanya S Utay
Current Opinion in HIV and AIDS|January 6, 2016
Role of immune activation in progression to AIDSNetanya S Utay, Peter W Hunt
Current HIV/AIDS Reports|February 10, 2015
Type I interferon: understanding its role in HIV pathogenesis and therapySteven E Bosinger, Netanya S Utay
Tropical Diseases, Travel Medicine and Vaccines|September 9, 2017
Hepatic steatosis in HCV-infected persons in the direct-acting antiviral eraHeather L Stevenson, Netanya S Utay
Pathogens & Immunity|August 9, 2016
Interferons and HIV Infection: The Good, the Bad, and the UglyNetanya S Utay, Daniel C Douek
Expert Opinion on Investigational Drugs|December 16, 2015
Peginterferon α-2a for the treatment of HIV infectionDavid M Asmuth, Netanya S Utay, Richard B Pollard
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|May 28, 2025
Low Rate of Documented Measles Immunity in a Large Urban HIV ClinicHayden S Andrews, Hannah L Blanchard, Shining Yang, et al.
Transactions of the American Clinical and Climatological Association|July 18, 2020
THE INTESTINAL MICROBIOME IN HUMAN HEALTH AND DISEASEHerbert L Dupont, Zhi-Dong Jiang, Andrew W Dupont, et al.
Digestive Diseases and Sciences|February 3, 2020
Abnormal Intestinal Microbiome in Medical Disorders and Potential Reversibility by Fecal Microbiota TransplantationHerbert L DuPont, Zhi-Dong Jiang, Andrew W DuPont, et al.
Pageof 6